Currently, a clinical research study is under way to evaluate the safety and tolerability of an investigational drug for moderate to severe psoriasis. Psoriasis is a chronic recurring disorder affecting 2-3% of people in Western populations.  If you have psoriasis, you may be eligible to participate in this important clinical research study. You may qualify to participate if you:

Have been diagnosed with moderate to severe psoriasis for at least 6 months

Are between the ages of 18 and 55

You will receive study-related health examinations at no cost. Qualified participants will receive study related medication and care at no cost.  Other eligibility criteria will apply and insurance is not required.  Compensation for time and travel up to $1,050.00 may be provided. To find out more about this clinical research study please contact MCRC at 214-424-0405 or on the web at www.mcrcdallas.com.

If you have been told in the last 6 months that you have Psoriatic Arthritis, consider volunteering for a clinical research study.  Metroplex Clinical Research Center is currently conducting a clinical research study of an investigational medication for Psoriatic Arthritis.  If you are at least 18 years old, have been diagnosed with Psoriatic Arthritis for 6 months you may be eligible.  Qualified participants will receive study medication and study-related care at no cost.  Other eligibility criteria will apply and insurance is not required.  To find out more about this clinical research study please contact MCRC at 214-424-0405 or on the web at www.mcrcdallas.com.

Currently, a clinical research study is under way to evaluate the safety and effectiveness of an investigational drug for people living with subacute cutaneous lupus erythematosus (SCLE) every day.  If you have SLE and have not had any recent changes in disease activity, you may be eligible to participate in this important clinical research study. You may qualify to participate if you:

Are between 18 to 70 years old

Have a confirmed diagnosis of subacute cutaneous lupus erythematosus

You will receive study-related health examinations at no cost. Qualified participants will receive study related medication and care at no cost.  Other eligibility criteria will apply and insurance is not required.  Compensation for time and travel up to [XXXX] may be provided. To find out more about this clinical research study please contact MCRC at 214-424-0405 or on the web at www.mcrcdallas.com.

Currently, a clinical research study is under way to evaluate the safety and tolerability of an investigational drug for people living with discoid lupus every day. Discoid lupus is a chronic skin condition of sores with inflammation and scarring.  If you have DLE you may be eligible to participate in this clinical research study. You may qualify to participate if you:

Are between 18 to 70 years old

Have a confirmed diagnosis of discoid lupus erythematosus

Qualified participants will receive study related medication and care at no cost.  Other eligibility criteria will apply.  Compensation for time and travel up to may be provided. To find out more about this clinical research study please contact MCRC at 214-424-0405 or on the web at www.mcrcdallas.com.  This study is for research purposes only and is not intended to treat your medical condition.

Currently, clinical research study is under way to evaluate the safety and effectiveness of an investigational drug for people living with Systemic Lupus Erythematosus (SLE) every day. SLE is the most common type of lupus, which mainly strikes young women of African, Hispanic, and Asian descent.  If you have SLE, you may be eligible to participate in this important clinical research study. You may qualify to participate if you:

Are between 18 and 75 years old

Have a confirmed diagnosis of Systemic Lupus Erythematosus

Qualified participants will receive study related medication and care at no cost.  Other eligibility criteria will apply and insurance is not required.  Compensation for time and travel may be provided if you qualify for the study. To find out more about this clinical research study please contact MCRC at 214-424-0405 or on the web at www.mcrcdallas.com.

Have you been diagnosis with early rheumatoid arthritis?  Metroplex Clinical Research Center (MCRC) is conducting a clinical research study for the combination therapy of Humira and Methotrexate.  If you are at least 18 years of age and have been diagnosed within the last 12 months you may qualify.  Qualified participants will receive study related medication and care at no cost.  Other eligibility criteria will apply and insurance is not required.  Compensation for time and travel up to$810.00. To find out more about this clinical research study please contact MCRC at 214-424-0405 or on the web at www.mcrcdallas.com.

Do you have moderate to severe RA?  Metroplex Clinical Research Center (MCRC) is conducting a clinical research study for Rheumatoid Arthritis.  If you are currently receiving treatment with Methotrexate and never received treatment with a biologic drug you may be eligible. Qualified participants will receive study related medication and care at no cost.  Other eligibility criteria will apply and insurance is not required.  Compensation for time and travel up to $696. To find out more about this clinical research study please contact MCRC at 214-424-0405 or on the web at www.mcrcdallas.com.

Do You Have Rheumatoid Arthritis?  Metroplex Clinical Research Center (MCRC) is conducting a clinical research study for Rheumatoid Arthritis.  If you are between 18 and 70 years of age and have been diagnosed with Rheumatoid Arthritis you may qualify.  Qualified participants will receive study related medication and care at no cost.  Other eligibility criteria will apply and insurance is not required.  Compensation for time and travel up to $450.00. To find out more about this clinical research study please contact MCRC at 214-424-0405 or on the web at www.mcrcdallas.com.

Currently, clinical research study is under way to evaluate the safety and effectiveness of an investigational treatment for people living with rheumatoid arthritis. Rheumatoid arthritis causes chronic inflammation of the joints.  If you have been diagnosed with rheumatoid arthritis, you may be eligible to participate in this important clinical research study. You may qualify to participate if you:

Are between the age of 18 and 75 years old

Have a confirmed diagnosis of rheumatoid arthritis

   Have tried more than 2 therapies with no success

You will receive study-related health examinations at no cost. Qualified participants will receive study related medication and care at no cost.  Other eligibility criteria will apply.  Reimbursement for time and travel up to [XXXX] may be provided. To find out more about this clinical research study please contact MCRC at 214-424-0405 or on the web at www.mcrcdallas.com.

Currently, a clinical research study is under way to evaluate different dose levels of an investigational drug.  Rheumatoid arthritis causes chronic inflammation of the joints.  If you have RA, you may be eligible to participate in this important clinical research study. You may qualify to participate if you:

Are between 18 to 75 years old

Have a confirmed diagnosis of rheumatoid arthritis

You will receive study-related health examinations at no cost. Qualified participants will receive study related medication and care at no cost.  Other eligibility criteria will apply and insurance is not required.  Compensation for time and travel up to $2,075.00 may be provided. To find out more about this clinical research study please contact MCRC at 214-424-0405 or on the web at www.mcrcdallas.com.